Drug Shortage Report for DOPAMINE HCL 3.2MG/ML DEXTROSE 5% INJ USP
| Report ID | 171105 |
| Drug Identification Number | 00761834 |
| Brand name | DOPAMINE HCL 3.2MG/ML DEXTROSE 5% INJ USP |
| Common or Proper name | DOPAMINE HCL 3.2MG/ML DEXTROSE 5% INJ USP |
| Company Name | BAXTER CORPORATION |
| Market Status | MARKETED |
| Active Ingredient(s) | DEXTROSE DOPAMINE HYDROCHLORIDE |
| Strength(s) | 50MG 3.2MG |
| Dosage form(s) | SOLUTION |
| Route of administration | INTRAVENOUS INTRAVENOUS |
| Packaging size | 250mL |
| ATC code | C01CA |
| ATC description | CARDIAC STIMULANTS EXCL. CARDIAC GLYCOSIDES |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2022-10-04 |
| Actual start date | 2022-10-04 |
| Estimated end date | 2022-11-30 |
| Actual end date | 2022-11-30 |
| Shortage status | Resolved |
| Updated date | 2022-12-01 |
| Company comments | Baxter products Dopamine Hydrochloride and 5% Dextrose USP – 400mg/250mL bags (DIN 00761826) and 200mg/250mL bags (DIN 00761850) are available as alternatives if they align with clinical practice. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 7125 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 0C2 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v6 | 2022-12-01 | English | Compare |
| v5 | 2022-11-30 | French | Compare |
| v4 | 2022-11-30 | English | Compare |
| v3 | 2022-10-05 | English | Compare |
| v2 | 2022-10-04 | French | Compare |
| v1 | 2022-10-04 | English | Compare |
Showing 1 to 6 of 6